ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,583.60
(
0.75%
)
US Tech 100
15,614.00
(
1.38%
)
Dow Jones
36,124.55
(
0.19%
)
Brent Oil
74.22
(
-0.17%
)
Bitcoin
43,437.37
(
-0.75%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Intercept Pharmaceuticals Inc (ICPT)

  7. Intercept Pharmaceuticals Inc (ICPT) News

ICPT Intercept Pharmaceuticals Inc

19.00
0.00 (0.0%)
Last Updated: 19:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Intercept Pharmaceuticals Inc ICPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 19.00 19:00:00
Open Price Low Price High Price Close Price Prev Close
19.00
more quote information »

Recent News

Date Time Source Heading
11/20/202312:09EDGAR2Form 15-12G - Securities registration termination [Section..
11/15/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/13/202314:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202314:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202308:00GLOBEIntercept Announces New Phase 2 Data Showing Significant..
11/10/202308:00GLOBEIntercept Announces New Findings from Long-term Extension of..
11/08/202316:44EDGAR2Form 8-K - Current report
11/08/202316:28EDGAR2Form POS AM - Post-Effective amendments for registration..
11/08/202316:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/08/202309:21EDGAR2Form 25-NSE - Notification filed by national security..
11/08/202309:13GLOBEAlfasigma completes acquisition of Intercept..
11/08/202307:50EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/08/202306:04EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/06/202317:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202309:10EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
10/30/202308:49EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/26/202309:07EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
10/26/202308:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/18/202309:02EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
10/17/202317:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
10/11/202316:34EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10/11/202316:16EDGAR2Form SC TO-T - Tender offer statement by Third Party
10/10/202311:10EDGAR2Form SC TO-C - Written communication relating to an issuer..
9/28/202317:17EDGAR2Form SC14D9C - Written communication relating to third party..
9/26/202317:06EDGAR2Form SC14D9C - Written communication relating to third party..
9/26/202312:43EDGAR2Form SC TO-C - Written communication relating to an issuer..
9/26/202308:28EDGAR2Form 8-K - Current report
9/26/202308:00GLOBEAlfasigma to Acquire Intercept Pharmaceuticals for $19.00..
9/25/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/18/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/05/202308:30GLOBEIntercept Pharmaceuticals to Conduct Fireside Chats and..
8/03/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/02/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/02/202307:05EDGAR2Form 8-K - Current report
8/02/202307:00GLOBEIntercept Pharmaceuticals Reports Second Quarter 2023..
7/26/202308:00GLOBEIntercept to Announce Second Quarter 2023 Financial Results..

Your Recent History

NASDAQ
ICPT
Intercept Pharmaceuticals
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com